As the year draws to a close, we at The Concinnity Company are proud to celebrate an extraordinary 2024. Fueled by our commitment to address Centralization, Collaboration, and Compliance challenges in clinical trials, we’ve worked alongside the world’s largest CROs and sponsors to transform clinical trial oversight with process intelligence. This year has been a testament to our mission of streamlining processes and advancing clinical trial coordination.
Milestones That Defined 2024
Geometric growth in Platform Adoption: 250+% growth.
Our sponsor count surged by an impressive 260%, reflecting the growing trust in our platform as a solution for managing increasingly complex trials. This milestone underscores our strengthened market presence and the growing demand for centralized, compliant trial oversight. Fueled by a 254% increase in active studies, for 320% more unique users, our platform has become the preferred choice for clinical trial coordination. This exponential growth not only reflects user trust but also strengthens the collaborative power of our growing network.
As digitalization of trial processes accelerates, Cloud Concinnity continues to lead the way by centralizing documentation and processes, eliminating the use of disparate point solutions that are inefficient and increases the risk of data leaks/compliance issues.
2. Top Pharma Tech Software Provider Recognition
For the second year in a row, Cloud Concinnity was recognized by multiple industry leaders as a Top E-Clinical Trial Management Solution, further solidifying our standing as an industry leader and a trusted partner in clinical trial management.
Ensuring seamless coordination among multiple stakeholders is complex and resource-intensive. Cloud Concinnity enables a unified process of conducting independent safety review, avoiding cumbersome and time consuming document collaboration with emails and/or various document repositories.
3. Partnering with Industry Leaders to Improve the Platform
User feedback has been central to our success in continuously expanding and improving the platform. In 2024, we delivered quarterly software updates, enhancing functionality, performance, and user experience. These updates ensure our platform remains scalable, meeting the demands of a rapidly evolving clinical trial landscape.
4. Sustaining Part 11 Compliance
Compliance is integral to our mission, so maintaining Cloud Concinnity as a validated Part 11 compliance platform is important to us. In 2024 we completed rigorous audits, both internal and external, demonstrating our meeting of those requirements.Every software update adheres to exacting regulatory standards, ensuring trust and reliability for our clients.
Regulatory/compliance teams and study requirements are unique and must follow FDA and Charter specs. For organizations to be ever audit-ready, Cloud Concinnity provides a secure, centralized, and compliant foundation for reporting.
5. Expansion of Academic Medical Center Solutioning
This year marked a significant milestone as we partnered with a leading academic medical center research institution. Through this collaboration, Cloud Concinnity demonstrated its versatility across multiple use cases, showcasing its potential to revolutionize clinical research within academia. As we expand our academic partnerships, early adopters will play a pivotal role in shaping the future of trial coordination and gain exclusive access to tailored implementation support.
6. Strategic Team Growth
To support our expanding client base and the growing recognition of the imperative to digitalize trial processes, we grew our team this year with new industry expertise in functional areas and on our Clinical Trial Advisory Council, ensuring delivery of the best software and service for organizations transitioning to technology supported clinical trial oversight.
A Vision for 2025 and Beyond
As we reflect on the progress made in 2024, our focus now shifts to the future. With every partnership and every update, we are shaping a world where centralization of processes, collaboration across stakeholders, and compliance with regulations drive better outcomes for clinical trials.
By continuing to harness process intelligence and fostering innovation, we aim to empower our clients to stay ahead in an ever-changing industry. Together, let’s build a smarter, more efficient future for clinical trial coordination.
Here’s to an exciting 2025!